Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 76282-448

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 76282-448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 10/12.5 mg (90 tablets)

Lisinopril And Hydrochlorothiazide Tablets  10/12.5 mg (90 tablets)
Label for Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg strength, oral tablet form. The label shows the product name prominently with the strength highlighted in yellow. It includes the Exelan Pharmaceuticals, Inc. logo and indicates a package count of 90 tablets. Storage instructions, dosage notes, and manufacturer details for InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc. are also present.*
FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 20/12.5 mg (90 tablets)

Lisinopril And Hydrochlorothiazide Tablets  20/12.5 mg (90 tablets)
Label for Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/12.5 mg, oral tablets. The label shows the product name prominently with strength highlighted in a teal box. The label indicates the package contains 90 tablets. The labeler is Exelan Pharmaceuticals, Inc. Additional information includes storage instructions, manufacturing details by InvaGen Pharmaceuticals, Inc., and a barcode on the left side.*
FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 20/25 mg (90 tablets)

Lisinopril And Hydrochlorothiazide Tablets  20/25 mg (90 tablets)
Label for Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/25 mg, oral tablets. The label shows the product name, strength, a count of 90 tablets, and the labeler Exelan Pharmaceuticals, Inc. The label also includes storage instructions, manufacturer details (InvaGen Pharmaceuticals, Inc.), and a barcode.*
FDA Label Image

Structural Formula 1 (Image 01)

Structural Formula 1 (Image 01)
Chemical structure of lisinopril, an active ingredient in Lisinopril and Hydrochlorothiazide tablets. The diagram shows the molecular framework including phenyl, amide, and carboxyl functional groups, as well as attached water molecules (2H2O).*
FDA Label Image

Structural Formula 2 (Image 02)

Structural Formula 2 (Image 02)
Chemical structure of the active ingredient Lisinopril and Hydrochlorothiazide, depicting the molecular composition including sulfonamide, chlorine atoms, and nitrogen-containing rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.